Effects of somatostatin analogue SMS 201–995
✍ Scribed by G. J. Poston; J. Gillespie; D. M. Nott; J. N. Baxter; T. G. Cooke; S. A. Jenkins
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 296 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Somatostatin inhibits exocrine pancreatic and has been used for treatment of pancreatic f i ~t u l a ~-~. The short ti, < 3 m i n in man6, and the risk of a rebound effect when treatment is interrupted7, require the peptide to be continuously infused intravenously. This may be circumvented by using
Abstract The dumping syndrome, which may follow partial gastrectomy or truncal vagotomy and drainage, may be refractory to treatment. The aim of this study was to determine the effect of the somatostatin analogue. SMS 201-995 (octreotide), on dumping provoked by hypertonic glucose. Ten patients with